HOME
ABOUT US
OUR COMPANY
OUR TEAM
BOARD OF DIRECTORS
INVESTORS
CAREERS
T-GUARD®
CHARACTERISTICS
DEVELOPMENT PLAN
GRAFT-VERSUS-HOST
ADDITIONAL INDICATIONS
EXPANDED ACCESS
A PATIENT’S STORY
NEWS & EVENTS
NEWS
EVENTS
IN THE MEDIA
PUBLICATIONS
PARTNERING
PARTNERING FOR PROGRESS
CONTACT
✕
2018
Filter by
Languages
Skill level
Authors
Show all
All
Geen categorie
Press-releases
All
2022
2021
2019
2018
2017
2016
2015
2014
2013
2012
All
MauriceHampsink
20 december 2018
20 december 2018
Xenikos partners with the BMT CTN to conduct a U.S.-based Phase 3 trial to test T-Guard® in aGVHD
16 november 2018
16 november 2018
Final results from T-Guard® Phase 1/2 trial in steroid-resistant aGVHD published in journal BBMT
14 mei 2018
14 mei 2018
Dutch Company Xenikos Secures USD 30 Million in Series B Financing
